Skip to content
HeyJared

Ed Cara

STORY ANGLES - Focuses on regulatory and policy decisions: Covers votes and recommendations by health authorities like the CDC and ACIP, emphasizing their broader implications.

Reporter · US

Indexed articles, last 90 days
88
Latest publication
Sep 30, 2026
Outlet visibility, for Gizmodo
Top 50K sites
Earliest in this view
Jul 6, 2026

Latest articles

  1. Article · Sep 30, 2026 · Ed Cara

    This Pill Will Change Cancer Treatment Forever (opens the original)

    Excerpt · Positive tone · English

    Read excerpt

    Revolution Medicines is the winner of the 2026 Gizmodo Science Fair for its research and development of Rasonque (daraxonrasib), the first approved cancer drug of its kind. Can we find an effective and reliable treatment for pancreatic cancer, which currently only has a five-year survival rate of 13%? In a large-scale clinical trial of 500 people with metastatic pancreatic ductal adenocarcinoma (the most common form of pancreatic cancer), people on daraxonrasib lived twice as long as those on st

  2. Article · Sep 28, 2026 · Ed Cara

    Scientists Uncover Worrying Link Between Frequent Cannabis Use and Seizures (opens the original)

    Excerpt · English

    Read excerpt

    Cannabis has arguably become the most popular recreational drug in the U.S. in recent years—with more Americans now consuming it daily than cigarette smoking and even alcohol. Research out today highlights a possible dark side to frequent cannabis use for at least some people, however: a greater risk of worsening seizures. Researchers at the Washington University School of Medicine in St. Louis studied people with treatment-resistant epilepsy, and found that people who reported frequent cannabis

  3. Article · Sep 26, 2026 · Ed Cara

    Living Drugs Transformed Blood Cancer Treatment—and That's Just the Beginning (opens the original)

    Excerpt · Neutral tone · English

    Read excerpt

    Given all the understandable pessimism there is about the world, you might not realize that we’re living in a golden era of cancer treatment. In January, the American Cancer Society reported that the five-year survival rate of cancer in the U.S. is now 70%—the highest mark reached to date. Preventive screening programs and the decline in major risk factors like smoking have played a big role in that success, to be sure, but doctors today are also able to treat and manage cancers that were once c

  4. Article · Sep 24, 2026 · Ed Cara

    More Than 1 Million Americans Are Taking Ozempic and Other GLP-1s Without an Approved Reason. Is That Actually a Problem? (opens the original)

    Excerpt · Critical tone · English

    Read excerpt

    GLP-1 medications like semaglutide (Ozempic and Wegovy) and tirzepatide (Mounjaro and Zepbound) have fast become some of the most recognizable and popular drugs in the world. Recent research now shows that a sizable number of Americans have been taking GLP-1s off-label. Scientists at New York University and others examined the medical records of Americans across the country. Since 2021, they found that at least 1.1 million Americans were prescribed a GLP-1 without having an FDA-approved indicati

  5. Article · Sep 24, 2026 · Ed Cara

    These Scientists Are Charting a New Future for Organ Transplantation—and It Starts With Pigs (opens the original)

    Excerpt · Positive tone · English

    Read excerpt

    Researchers at the NYU Langone Transplant Institute are the winners of the 2026 Gizmodo Science Fair for their ongoing work in developing animal-to-human transplantation, also known as xenotransplantation. Can we ever create a reliable and safe supply of new organs for those who need them? In September 2021, Robert Montgomery and his team performed a novel procedure: the first transplantation of a genetically modified pig organ into a still-intact human body. The family of a neurologically dead

Publishing over time

Last 90 days. Choose a month to open its work.

Recurring subjects

Named in the text we hold. One piece can cover several.

Audience

Top 50K sites

For Gizmodo, the outlet · Measured Aug 1, 2026

Website popularity band, not a count of readers or article views.

About this data

Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.

Identity or attribution wrong? Suggest a correction.

See coverage about Ed Cara